Cited by 761Virus-based gene therapy researchRNA Interference and Gene DeliveryBacteriophages and microbial interactions

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors

Open access

Ferrari, F K, Samulski, T, Shenk, T, Samulski, R J·1996·Journal of Virology

DOI 10.1128/jvi.70.5.3227-3234.1996PMC PMC190186

Open this paper in CoChat — free account

Abstract

The ability of recombinant adeno-associated virus (AAV) to transduce cells with a marker gene in vitro was found to be substantially increased by the presence of adenovirus. Transfection experiments with adenovirus genomic DNA suggest that this increase is not facilitated by adenovirus-mediated viral uptake but is instead dependent on adenovirus gene expression. Using various adenovirus mutants, we were able to map this function to early-region E4 open reading frame 6. Plasmid expression of open reading frame 6 protein in cells infected with recombinant AAV increased transduction between 100- and 1,000-fold. The increase in transduction was not dependent on the recombinant AAV gene cassette but instead appeared to involve an immediate early step of the AAV life cycle. Chemical and physical agents that have been shown to induce helper-free replication of wild-type AAV were also able to stimulate recombinant AAV transduction, suggesting that the phenomenon might affect AAV DNA replication. Further experiments showed that viral uncoating was not affected and that the rate-limiting step involved synthesis of a second strand on the single-stranded genomic AAV DNA. These data suggest that the adenovirus E4 region, as well as chemical and physical agents, can play an essential role in an immediate-early step of the AAV life cycle, specifically in second-strand synthesis, and have important implications for the use of AAV vectors in gene therapy protocols.

Integrity signals

Registry

Crossref · 10.1128/jvi.70.5.3227-3234.1996

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Use of a recombinant retrovirus to study post‐implantation cell lineage in mouse embryos.
Sanes, J. R., Rubenstein, J. L. R., & Nicolas, J. F. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04620.x · Cited by 1,116
Untitled work
(1952) · Cancer Research · Cited by 987
Site-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 906
Self-citation
Site-specific integration by adeno-associated virus.
Linden, R. M., Ward, P., Giraud, C., Winocour, E., & Berns, K. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11288 · Cited by 805
Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells
Jones, N. C., & Shenk, T. E. (1979) · Cell · doi:10.1016/0092-8674(79)90275-7 · Cited by 784
Self-citation
Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.
Samulski, R. J., Zhu, X., Xiao, X., Brook, J. D., Housman, D. E., Epstein, N., & Hunter, L. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04964.x · Cited by 783
Self-citation
Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression
Samulski, R. J., Chang, L., & Shenk, T. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 742
Self-citation

Show all 46 references

Sorted by citations

Items 701–758 of 758

Adeno-associated virus (AAV) vector mediated transgene expression in cell line derived from maxillary cancer.
Kanazawa, T., Urabe, M., Kume, A., Nishino, H., Monahan, J., Ozawa, K., & Kitamura, K. (1999) · Japanese jornal of Head and Neck Cancer · doi:10.5981/jjhnc1974.25.148
Antiangiogene Gentherapie mittels eines modifizierten AAV-Vektors
Cramer, P. (2008)
"Quantifizierung infektiöser rekombinanter AAV9-Partikel mittels Real-Time PCR"
Lauster, R. (2015)
Molekulare Therapie der pulmonalen Erkrankung der CF
Bals, R., Randak, C. O., Reinhardt, D., & Rosenecker, J. (2001) · Springer eBooks · doi:10.1007/978-3-642-56796-4_15
Gene therapy and viral vectors. Preface: Current status of gene therapy and viral vectors.
Ozawa, K. (1997) · Uirusu · doi:10.2222/jsv.47.195
[Effect of DNA topoisomerase I inhibitor on the transduction efficiency of an deno-associated virus vector in human airway epithelial cells].
Teramoto, S., Matsuse, T., Ohga, E., Katayama, H., Fukuchi, Y., & Ouchi, Y. (1997) · PubMed
The Scope of Viral Vectors for the Transduction of Haemopoietic Cells
Lea, N. C., & Mufti, G. J. (1998) · Hematology · doi:10.1080/10245332.1998.11746378
Parvovirus Vectors for the Gene Therapy of Cancer
Wong, K. K., & Chatterjee, S. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50004-5
Ylkmsduction of hepatocellular carcinoma @ICC) using recombinant adeno-associated virus (rAA..: in vitro and in viva effwts of genotoxic agents
Peng, D., Qian, C., Sun, Y., Barajas, M., & Prìeto, J. (2000)
Modulation of adeno-associated virus transduction by the promyelocytic leukemia protein, arsenic trioxide, and proteasome inhibitors
Mitchell, A. M. (2013) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/f5kg-n202
The Role of Assembly-Activating Protein in the Capsid Assembly of Different Adeno-Associated Virus Serotypes
Earley, L. F. (2016) · doi:10.6083/m4c24vg2
Investigating the physiological role of hypothalamic glucokinase in appetite and glucose homeostasis
Hussain, S. S. (2013) · Spiral (Imperial College London) · doi:10.25560/14696
Gene Transfer in Spinal Muscular Atrophy
Foust, K. D., & Kaspar, B. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803685-3.00019-7
Chemical Modulation of AAV Trafficking
Berry, G. E. (2016) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/dpe3-gy73
Virus-mediated Delivery of the Fmr1 Gene as a Tool for the Treatment of Fragile X Syndrome
Moghaddam, S. G. (2016) · TSpace (University of Toronto)
recombinant AAV vectors in human cell lines in vitro and in murine hepatocytes in
Ling, C., Wang, Y., Lu, Y., Wang, L., Jayandharan, G. R., George, V., Li, B., Cheng, B., Ma, W., Lentz, T. B., et al. (2014)
Self-citation
Intravenously administered gene therapy for neuronopathic Gaucher disease
Massaro, G. (2018) · UCL Discovery (University College London)
Novel Approaches for Pluripotent Reprogramming
Weltner, J. (2018) · Työväentutkimus Vuosikirja
Therapy and mechanism of Mendelian eye diseases
Tsai, Y.-T. (2018) · doi:10.7916/d8k37bhv
Broad strategies into engineering superior targeted gene therapy vectors derived from bacteriophage viruses
Tsafa, E. (2016) · doi:10.25560/61571
Pharmacological and Biophysical Dissections of the Trafficking and Infection of Adeno-Associated Virus (AAV) In Vitro and In Vivo
Xiao, P. (2013) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/rn9x-xq74
Understanding mechanisms of Adeno-associated virus vector transduction through pharmacological and biological approaches
Nicolson, S. C. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/gbv4-z740
Gene Therapy for Retinal Disease
McClements, M. E., & MacLaren, R. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00011-7
Gene and cell based therapies for the prevention and treatment of supraventricular arrhythmias
Hoffman, J. A., Trivedi, A. D., & Arora, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813704-8.00034-6
Genetic Vaccines and Therapy
Zhong, S., Sun, S., & Teng, B. (2015)
Genetic Vaccines and Therapy
Stiefelhagen, M., Sellner, L., Kleinschmidt, J. A., Jauch, A. S., Laufs, S., Wenz, F. K., Zeller, W. J., Früehauf, S., & Veldwijk, M. R. (2015)
Bioprocess improvement for manufacturing of recombinant adeno-associated virus-based gene delivery vectors
Joshi, P. (2021) · doi:10.82308/30015
Rescue of inherited retinal degeneration associated with Aipl1 defects
Ku, C. A. (2012) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.4880
マルチトーン信号のピーク対平均電力比(PAPR)を低減する初期位相設定法
楢橋, 祥., & 野島, 俊. (1995)
Prospects for Gene Therapy of Inherited Immunodeficiency
Casimir, C. M. (1999) · Blood cell biochemistry · doi:10.1007/978-1-4615-4889-8_6
Genetic Modification of Neural Stem/Progenitor Cells
Wu, P., & Xiao, W. (2003) · Springer eBooks · doi:10.1007/0-306-48356-4_14
Symposium session summaries
(1996) · Pediatric Pulmonology · doi:10.1002/ppul.1950220705
Annotated References by Year
(2001) · Elsevier eBooks · doi:10.1016/b978-012455851-9/50085-7
Symposium session summaries
(1997) · Pediatric Pulmonology · doi:10.1002/ppul.1950230705
Transmembrane Channel-Like (Tmc) Gene Therapy Restores Auditory Function in Deaf Mice
Askew, C. (2015) · doi:10.18130/v3825c
Adeno-Associated Viral Vectors: Principles and in Vivo Use
Danos, O. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46860-3_91
Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Tran, N. M., Xu, X., Qi, L. S., & Hu, Y. (2024) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-99-4436-1_19
New hope for older SMA patients with next-generation self-complementary AAV gene therapy
Nakai, H., Finanger, E. L., & Samulski, R. J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.013
Self-citation
Longitudinal assessment of DREADD expression and efficacy in the monkey brainPreprint
Nagai, Y., Hori, Y., Inoue, K., Hirabayashi, T., Mimura, K., Oyama, K., Miyakawa, N., Hori, Y., Iwaoki, H., Kumata, K., et al. (2025) · eLife · doi:10.7554/elife.105815.2
Structural analysis of recombinant AAV vector genomes at single-molecule resolution
Rouleau, D., Lata, D., Dollive, S., Bruccoleri, R. E., van Lieshout, L. P., Golebiowski, D., & Iwuchukwu, I. (2026) · PLoS ONE · doi:10.1371/journal.pone.0339201
UDP-glucuronosyltransferases in sickness and health : Studies on bilirubin and steroid glucuronidation
Sneitz, N. (2013) · Työväentutkimus Vuosikirja
Hemophilia Gene Therapy
Walsh, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00013-0
Selection and characterization of targeted vector capsids from random adeno-associated virus type 2 (AAV-2) display peptide libraries
Michelfelder, S. (2008)
Comparison of AAV9-driven motor neuron transduction following different CNS-directed delivery methods in mice
Mole, A. J., Sander, C. F., Parmar, A., Williams, A. J., Azzouz, M., Hautbergue, G. M., Shaw, P. J., Ferraiuolo, L., & Mead, R. J. (2026) · Scientific Reports · doi:10.1038/s41598-026-38039-z · Cited by 1
Orthogonal characterization of rAAV reveals vector attributes that drive ITR repair, self-complementary genome formation, and transgene expression
Llinares, C., Namkung, S., Yip, M., Vales, Á., Olagüe, C., Mauleón, I., Isola, S., Moeini, P., González‐Aseguinolaza, G., Tai, P. W. L., et al. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102899
Nouveaux outils exploratoires et développement d'approches thérapeutiques dans les dysferlinopathies primaires
Wein, N. (2010) · theses.fr (ABES) · doi:10.70675/a98d6eb4zdc4fz4a37z896fz84b17c1cae24
Thermostability of Adeno-Associated Virus (AAV) Vectors
Pacouret, S. (2018) · theses.fr (ABES) · doi:10.70675/33e13ef9z7aefz418dz8fdez21352cc194bc
Physical properties of R-Loops and viral capsids : a single molecule approach based on AFM high resolution imaging and nano-indentation
Salas, Y. C. (2021) · theses.fr (ABES) · doi:10.70675/81be124dzc634z4571z82ccz07f88cbb7520
Balance entre rejet et tolérance : la bipolarité immunitaire du muscle squelettique face à l’AAV recombinant : décryptage de la réponse immune de l’hôte dirigée contre le produit du transgène après injection de vecteurs AAV recombinants par voie intramusculaire
Journou, M. (2021) · theses.fr (ABES) · doi:10.70675/9a618ac2za0a4z4e90zbdb3ze14482ffa655
A Mechanistic Model of rAAV Production in Synthetic Cell Lines
Srinivasan, P., Kuo, H., Lin, Y., Lu, Y., Hu, W., & Zhang, Q. (2026) · Biotechnology and Bioengineering · doi:10.1002/bit.70208
Intracellular trafficking and nuclear compartmentalization of AAV gene delivery
Hutchinson, T. E., Singh, R. E., Oliver, J. Y., Davis, A., Potter, M., Hsi, J., Mietzsch, M., Bennett, A. D., & McKenna, R. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201770
Spinal muscular atrophy: Biology, pathogenesis, and therapeutic advances
René, C. A., & Parks, R. J. (2026) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864261480901
In vivo base editing rescues hearing in humanized MPZL2 mice within a structure-dependent therapeutic windowPreprint
Lee, S., Bae, S., Jeong, S., Kang, B.-H., Choi, W. H., Choi, Y., Koo, H., Byun, W. S., Yun, Y., Jung, S. H., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10977804/v1
Adeno-associated virus-mediated epithelial IL-33 silencing attenuates type 2 airway inflammation
Tomiyasu, S., Kabata, H., Akiyama, Y., Ogawa, T., Koyama, K., Kurihara, M., Masaki, K., Miyata, J., Mizukami, H., & Fukunaga, K. (2026) · Allergology International · doi:10.1016/j.alit.2026.09.004
Systemic AAV-Mediated Gene Therapy Using Epo-R76E to Protect Retinal Ganglion Cells from Optic Nerve Injury and Disease
Sullivan, T. (2011) · doi:10.21007/etd.cghs.2011.0389
Gene Therapy for Advanced Prostate Cancer
Jimènez, J. A., Li, X., Gardner, T. A., & Kao, C. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-224-3_9
rAAV-Mediated Gene Transfer For Study of Pathological Mechanisms and Therapeutic Intervention in Canavan's Disease: A Dissertation
Ahmed, S. S. (2014) · eScholarship@UMassChan · doi:10.13028/m25s3r
AAV-mediated gene transfer to synovium: enhancing effects of inflammatory cytokines and proteasome inhibitors
Traister, R. S. (2006) · D-Scholarship@Pitt (University of Pittsburgh)

Authors: Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J.
Affiliations: University of North Carolina at Chapel Hill (US)
ORCID: Shenk, T
Venue: Journal of Virology
Publisher: American Society for Microbiology
Published: 1996-05
Volume: 70
Issue: 5
Pages: 3227-3234
ISSN: 0022-538X (ISSN-L)
1098-5514
DOI: 10.1128/jvi.70.5.3227-3234.1996
PMC: PMC190186
OpenAlex: W2165815741
Cited by: 761
References: 46
Citations by year: 2026: 13 · 2025: 16 · 2024: 16 · 2023: 17 · 2022: 13 · 2021: 15 · 2020: 25 · 2019: 17 · 2018: 15 · 2017: 10 · 2016: 22 · 2015: 27 · 2014: 21 · 2013: 17 · 2012: 27
FWCI: 24.99
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Virology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01dk042701-06)
National Heart, Lung, and Blood Institute (HL48327, P01HL051818, HL51818)
National Institute of Diabetes and Digestive and Kidney Diseases (DK 42701)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
Keywords: recombinant adeno-associated virus vectors, viral uncoating, gene therapy vectors
MeSH terms: Dependovirus, Adenoviridae, beta-Galactosidase, Cell Line, DNA, Viral, Genetic Vectors, HeLa Cells, Humans, Kinetics, Plasmids, Recombinant Proteins, Recombination, Genetic, Transduction, Genetic, Transfection, Ultraviolet Rays, X-Rays, Gene Expression, Mutagenesis, Open Reading Frames

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks